Limula
Cell & Gene Therapy: Automated. Scalable. Accessible
Epalinges, Switzerland
25 employees
Seed
Total: $14.04M
Biotechnology, Manufacturing +1
General Information
Epalinges, Switzerland
BounceWatch is an independent company data service, not affiliated with Limula. To contact Limula, visit limula.ch.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Switzerland Market
Biotechnology
About Limula
Taxonomy: Cell Therapy, Gene Therapy, Cancer Treatment, Personalized Medicine, Automated Manufacturing, Scalability, Process Analytics, Medical Innovation
Funding Rounds & Investors (12)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | Fr.6.20M | 6 |
|
21 May 2024 |
| Non Equity Assistance | Undisclosed | 1 |
Innovaud
|
09 Feb 2024 |
| Grant | $250.00K | 1 |
|
13 Oct 2023 |
| Grant | Fr.90.00K | 1 |
Biopôle
|
05 Oct 2023 |
| Grant | Fr.100.00K | 1 |
W.A. DE VIGIER
|
21 Jun 2023 |
| Non Equity Assistance | Undisclosed | 1 |
|
06 Jun 2023 |
| Grant | Fr.2.50M | 1 |
|
28 Apr 2023 |
| Grant | Fr.65.00K | 1 |
Biopôle
|
11 Oct 2022 |
| Grant | €4.70M | 1 |
|
15 Jun 2022 |
| Debt Financing | Fr.100.00K | 1 |
Foundation for Technological Innovation (FIT)
|
16 Feb 2022 |
Latest News
View All
Limula Alternatives & Competitors
We're on a mission to enable widespread patient access to a new generation of lifesaving Cell and Ge...
Your Advanced Cell & Gene Therapy CDMO Partner
An integrated cell and gene therapy Contract Testing, Development and Manufacturing Organization (CT...
FAQ About Limula
Source: BounceWatch company record for Limula, https://bouncewatch.com/company/limula, updated 30 December 2024. When citing, please name BounceWatch and link this page.
